2019

1. Enhanced antitumor efficacy of oncolytic adenovirus–loaded menstrual blood–derived mesenchymal stem cells in combination with peripheral blood mononuclear cells

   Molecular Cancer Therapeutics, Vol. 18, Núm. 1, pp. 127-138